• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 16, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Voluntary control of brainwaves in deep brain of patients with Parkinson's disease

Bioengineer by Bioengineer
February 6, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Patients with Parkinson’s disease can voluntarily control β waves in their deep brain, representing a new approach toward managing disease-related brain activity

IMAGE

Credit: Osaka University

Parkinson’s disease is associated with abnormal beta wave activity in the subthalamic nucleus (STN), but a direct connection between this activity and movement difficulties has not yet been established.

A study group at Osaka University developed a neurofeedback system (Figure 1) which enables patients with Parkinson’s disease to voluntarily control beta wave activity in their deep brain (STN, Figure 2) associated with symptoms of the disorder. The group demonstrated that the patients can control these beta waves voluntary; however, it remains to be determined whether such a system can provide symptom relief. The group’s research results were published in eNeuro.

“In a study of eight patients undergoing a routine replacement of a pulse generator used for deep brain stimulation, we developed a method that could help scientists better understand the relationship between brain activity and disease symptoms,” says senior author Haruhiko Kishima.

In this study, the patients were trained to increase the size of a black circle that changes according to the participants’ real-time beta wave activity. For half of the participants, the size of the black circle was positively correlated with beta wave intensity, and for other half of the participants, the circle was negatively correlated with beta wave intensity. After the 10 minutes of training, the study demonstrated that the patients’ beta waves significantly increased or decreased depending on the circle condition. Using the real-time feedback system, the patients can voluntarily control their beta waves.

Corresponding author Takufumi Yanagisawa says, “Although we did not observe an improvement in patients’ symptoms, our study represents a new approach toward managing disease-related brain activity that could lead to the development of new treatments.”

###

The article, “Real-Time Neurofeedback to Modulate β-Band Power in the Subthalamic Nucleus in Parkinson’s Disease Patients” was published in eNeuro at DOI: https://doi.org/10.1523/ENEURO.0246-18.2018.

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan’s leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan’s most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university’s ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: https://resou.osaka-u.ac.jp/en/top

Media Contact
Saori Obayashi
[email protected]
81-661-055-886

Original Source

https://resou.osaka-u.ac.jp/en/research/2018/20181218_1

Related Journal Article

http://dx.doi.org/10.1523/ENEURO.0246-18.2018

Tags: Medicine/HealthneurobiologyParkinson
Share12Tweet8Share2ShareShareShare2

Related Posts

Genkwanin Glycosides Boost Glucose Uptake in Fat

Genkwanin Glycosides Boost Glucose Uptake in Fat

August 16, 2025
Biosilica Nanoparticles Combat Liver Ischemia Injury

Biosilica Nanoparticles Combat Liver Ischemia Injury

August 16, 2025

Treg Therapy Boosts Pro-Inflammatory Th17 via IL-2

August 16, 2025

Intratracheal Budesonide Boosts Preterm Infant Lung Health

August 16, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    59 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Seismic Analysis of Masonry Facades via Imaging

Pediatric Pharmacogenomics: Preferences Revealed by Choice Study

Genkwanin Glycosides Boost Glucose Uptake in Fat

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.